TNFRSF8 and Hodgkins lymphoma: Immunotherapy of Hodgkin's lymphoma, however, has to take into account that the malignant CD30+ Hodgkin/Reed-Sternberg cells (H/RS) persist in small numbers in the lymphoma lesion and are accompanied by massive infiltrations with benign cells [2]–[5].